Checking your browser - reCAPTCHA
6d agoNews
Source
bskyChecking your browser - reCAPTCHApubmed.ncbi.nlm.nih.govTherapeutic evaluation of herbal poultice (Dimad) in the management of pain and disability of chronic migraine: A case report ▶️ Read Full Paper 📚 Source: Explore (New York, N.Y.) 👤 Creator: Khalid Rahim Wani et al. 📅 Date: 2026-06-18 #MigrainePaper #Migraine #PubMed
You might also wanna read
GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients
A study from the University of Naples found that liraglutide, a GLP-1 receptor agonist typically used for diabetes and obesity, significantl
medlink.com·7mo ago
Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials
Compass Pathways, a British biotech company, announced strong results from two late-stage trials showing that a synthetic form of psilocybin
economist.com·4mo ago
Transient functional improvements in advanced Alzheimer's disease following high-dose psilocybin: a case report
This case report describes an 80-year-old Japanese-American woman with advanced Alzheimer's disease (10-year history, 5 years of severe hypo
frontiersin.org·10d agoTherapeutic Use of Cannabis and Cannabinoids: A Review
jamanetwork.com·6mo ago
UCLA discovers first stroke rehabilitation drug to repair brain damage
stemcell.ucla.edu·1mo ago
CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds
A post hoc analysis of pooled data from two clinical trials found that the CGRP monoclonal antibody fremanezumab reduces the risk of weather
mdsc.pe·9h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.